"G.O.P. Plan on Pesticides Faces Revolt From MAHA Moms"
"The provision in the government funding bill could shield pesticide companies from billions of dollars in lawsuits."
"The provision in the government funding bill could shield pesticide companies from billions of dollars in lawsuits."
"The U.S. and U.K. are expected to sign a deal to bolster nuclear energy as President Trump travels to Britain."
"America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments."

Just under two months from the start of the annual global forum for managing climate change — the United Nations’ conference of parties beginning Nov. 10 in Belém, Brazil — our Backgrounder analysis laments the vanishingly small chance that nations will agree on managing steadily rising greenhouse gas emissions. A look at the obstacles, plus COP30 reporting challenges, from hotel expenses to diplomatic spin.
"Big Tech’s AI frenzy is pressing up electricity demand around the country. The power grid is stuck in natural gas-fuelled inertia, slow to bring new clean energy projects online and leaving consumers on the hook."
"In the most remote parts of Alaska, staying in touch can involve a bit more effort than sending a text. Cell service is spotty, highways are nonexistent, and the postal service remains a vital lifeline, delivering supplies and mail by plane. But for anyone who wants to broadcast a different kind of message — a reminder to pick up milk, for example, or birthday wishes — there’s always the Muktuk Telegram."
"USDA’s staffing cuts, scuttled conservation programs, and misdirected crop insurance are hitting farmers hard."
"A group of experts says Western states urgently need to cut water use to avert a deepening crisis on the Colorado River. The river’s major reservoirs are less than one-third full, and another dry winter would push reservoirs toward critically low levels."
"Both House and Senate lawmakers have advanced bills rejecting the Trump administration’s proposal to eliminate climate research at the weather agency."
"FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny."